Skip to main content
logo
  • Funds

    Fund Listing

    • Fund Explorer
    • Fund Managers
    • Fund Documents
    • How to Invest

    Featured Funds

    • JPMorgan Global Income Fund
    • JPMorgan Income Fund
    • JPMorgan Asia-focused Solutions
    • JPMorgan ASEAN Equity Fund
    • JPMorgan Global Equity Solutions
  • Insights

    Market Insights

    • Market Insights Overview
    • Guide to the Markets
    • Weekly Market Recap
    • On the Minds of Investors
    • Guide to China
    • Multimedia

    Portfolio Insights

    • Portfolio Insights Overview
    • Global Asset Allocation Views
    • Global Fixed Income Views
  • Investment Ideas
    • Managing Volatility
    • Growth Strategy
    • Income Strategy
    • Sustainable Investing
  • Resources
    • Announcements
    • Forms & Literature
    • About Mutual Funds
    • Investment Glossary
    • Insights App
  • About Us
  • Contact Us
  • Role
  • Country
  • Search
    Search
    Menu
    From diagnosis to investing: capturing medtech opportunities
    10/01/2021
    Capturing medtech opportunities as virtual healthcare gains momentum
    Medical Technology Image

    Key takeaways:

    • Telehealth is in the spotlight as the global public health crisis accelerated demand for contactless and virtual medical treatments.
    • Innovative technologies in healthcare have contributed significantly to improving patient care, presenting growth opportunities in medical technology (medtech) and digital health companies1.

    Telehealth on the rise

    Telehealth, a case of technology meeting healthcare, has become trendy in recent years.

    In Hong Kong, hospitals, clinics and telecommunications companies have been increasingly shifting medical services to patients’ homes2. Since the start of the global public health crisis, 95% of physicians have increased their use of video consultations by 50% to provide medical care to patients3, reducing patients’ and clinicians’ risk of exposure and infection.

     

    Remote patient monitoring and self-diagnostics, and trials of hybrid online-and-offline models are bringing new care models for patients amid accelerating investments in digital health, according to a McKinsey & Co. report4. The total venture capital investment into the digital health space stood at US$14.7 billion in 1H 2021, compared with investment of US$14.6 billion for the whole of 2020, and nearly twice the investment of US$7.7 billion in 20194.

    Additionally, structure trends of an ageing population, exponential increase in expenditure and the need for better efficiencies in the healthcare system are presenting long-term investment growth opportunities for the medtech industry1.

    Adding a robotics touch

    Medical organisations are increasingly harnessing smart technologies to accelerate efficiencies, reduce unnecessary treatments and improve preventive care.

    For example, some medtech companies have been applying machine learning and artificial intelligence (AI) technologies when designing and upgrading surgical robots, allowing for greater precision during surgical operations. This has resulted in shorter patient recovery time. In addition to AI innovation in diagnostics and surgery, advanced technologies in healthcare also provide investment exposure to medical devices.

    Taking more steps a day

    Additionally, supportive government initiatives such as using big data in smart healthcare - storing the residents’ lifelong health records in an encrypted format shared by private and public hospitals5 – could improve the healthcare service quality and have given the medtech industry a boost.

    Smart technologies have also started to integrate in the way people live. The Singapore government has a physical activity programme, the “National Steps Challenge” to promote healthy living. With step-trackers, residents are encouraged to walk more than 10,000 steps a day. Since its launch in November 2015, 70% of previously inactive participants have now averaged more than 7,000 steps per day, with 30% of participants clocking about 10,000 steps a day on average6.

    Taking more steps a day

    Additionally, supportive government initiatives such as using big data in smart healthcare - storing the residents’ lifelong health records in an encrypted format shared by private and public hospitals5 – could improve the healthcare service quality and have given the medtech industry a boost.

    Smart technologies have also started to integrate in the way people live. The Singapore government has a physical activity programme, the “National Steps Challenge” to promote healthy living. With step-trackers, residents are encouraged to walk more than 10,000 steps a day. Since its launch in November 2015, 70% of previously inactive participants have now averaged more than 7,000 steps per day, with 30% of participants clocking about 10,000 steps a day on average6.

    Conclusion

    The demand for telehealth, innovative AI technologies and medical devices is accelerating after the global public health crisis4. This rising demand is also driven by structural trends such as an increasingly ageing population in many major economies. Governments are also increasingly adopting innovative technologies to improve healthcare efficiencies and quality. Innovating medtech companies are thus presenting investors with exposure to long-term growth opportunities1 in the industry.

    This content represents our investment team’s current view and overall strategy provided for information only based on current market conditions not taking into consideration any specific investor’s investment objective and risk appetite. Not to be construed as investment recommendation or advice.

    Diversification does not guarantee investment return and does not eliminate the risk of loss.

    1. For illustrative purposes only based on current market conditions, subject to change from time to time. Not all investments are suitable for all investors. Exact allocation of portfolio depends on each individual’s circumstance and market conditions.
    2. Source: “Why telehealth?”, Smart Nation Singapore, updated as of 31.08.2021.
    3. Source: “Pulse of the industry: medical technology report 2020”, Ernst and Young , Fall 2020. Provided for information only to illustrate macro trends not to be construed as offer, research or investment advice.
    4. Source: “Telehealth: A quarter-trillion-dollar post COVID-19 reality?”, McKinsey & Company, 09.07.2021.
    5. Source: “Hong Kong Smart City Blueprint 2.0”, Innovation and Technology Bureau, Hong Kong, December 2020.
    6. Source: “National Steps Challenge & the Healthy 365 app”, Smart Nation Singapore, updated as of 30.08.2021.

    This advertisement or publication has not been reviewed by the Monetary Authority of Singapore. It does not constitute investment advice, or an offer to sell, or a solicitation of an offer to buy any security, investment product or service. Informational sources are considered reliable but you should conduct your own verification of information contained herein. Investment involves risk. Investments in funds are not deposits and are not considered as being comparable to deposits. Past performance is not indicative of future performance and investors may not get back the full or any part of the amount invested. Dividend distributions if any are not guaranteed and are made at the manager’s discretion. Fund’s net asset value may likely have high volatility due to its investment policies or portfolio management techniques. The value of the units in the scheme and the income accruing to the units, if any, may fall or rise. Funds which are invested in emerging markets, smaller companies and financial derivative instruments may also involve higher risks and are usually more sensitive to price movements. Any applicable currency hedging process may not give a precise hedge and there is no guarantee that any hedging will be successful. Investors in a currency hedged fund or share class may have exposure to currencies other than the currency of their fund or share class. Investors should make their own investigation or evaluation or seek independent advice prior to making any investment. Please refer to the Singapore Offering Documents (including the risk factors set out therein) and the relevant Product Highlights Sheet for details at https://am.jpmorgan.com/sg/en/asset-management/per/. To the extent permitted by applicable law, we may record telephone calls and monitor electronic communications to comply with our legal and regulatory obligations and internal policies. Personal data will be collected, stored and processed by J.P. Morgan Asset Management in accordance with https://am.jpmorgan.com/sg/en/asset-management/per/privacy-statement/. Issued by JPMorgan Asset Management (Singapore) Limited (Co. Reg. No. 197601586K). All rights reserved.

    OUR FOCUS FUNDS

    Equities

    • JPMorgan ASEAN Equity Fund
    • JPMorgan China A-Share Opportunities Fund
    • JPMorgan Emerging Markets Equity Fund
    • JPMorgan Emerging Markets Dividend Fund
    • JPMorgan Asia Growth Fund

    Asset Allocation

    • JPMorgan Global Income Fund
    • JPMorgan Asia Pacific Income Fund
    • JPMorgan Total Emerging Markets Income Fund
    • JPMorgan Global Macro Opportunities Funds

    Fixed Income

    • JPMorgan Income Fund
    • JPMorgan Global Bond Opportunities Fund
    See all funds

    RELATED ARTICLES

    Climate change: a sustainable investing megatrend

    We discuss five megatrends related to climate change and the investment implications.

    Read more

    Investing for a changing world

    We share our perspectives of sustainable investing in an overall portfolio.

    Read more

    Positioning a fixed income portfolio for rising rates? We share 3 pointers

    We share our perspectives on positioning for income as rates rise.

    Read more

    1Q 2022 outlook: bonds still matter even as inflation stays elevated

    We share our views on the bond themes and opportunities for the first quarter of 2022.

    Read more

    Seeking diversification in a ‘prosperity pot’ to help drive income opportunities

    Consider diversity across regions, assets and sectors in an income portfolio.

    Read more

    Seeking long-term growth opportunities among the old & new in ASEAN

    ASEAN is gaining momentum with its mix of old & new economies.

    Read more

    Emerging growth opportunities when consumption goes ‘all about me’

    We share our views on how increasing demand for personalised products and services presents growth opportunities.

    Read more

    2022 outlook: what’s top of mind for income & growth?

    We share our perspectives on the investment landscape for 2022 and the opportunities for income and growth.

    Read more

    Spotlight on healthcare investing: is the smart pen mightier than the sword?

    Increasing demand for healthcare services globally is presenting growth opportunities.

    Read more

    Seeking out income opportunities in dividend stocks amid uncertain times

    Dividend stocks are back on investors’ radar as relatively attractive opportunities are emerging.

    Read more

    Where we see income opportunities as the Fed winds down stimulus

    We share how we employ a flexible approach to tap into income opportunities.

    Read more

    Exploring the role of corporate credit in a diversified portfolio

    Income investors like us have stayed the course as market conditions evolve. Where do we see income opportunities?

    Read more

    4Q 2021 bonds: themes and opportunities as rates look set to rise

    Looking at bond themes and opportunities in the final quarter of 2021.

    Read more

    How smart city living is driving investing possibilities

    The investing potential of the future world – smart cities

    Read more

    Curious about income investing? We share 4 FAQs

    How much do you know about income investing amid an evolving market environment?

    Read more

    Harnessing smart bots as we #returntotheoffice

    Robotics application and machine learning are making their way into the office, presenting long-term growth opportunities.

    Read more

    Bonds 101: ‘ABS’ and ‘MBS’ as a diversifier in a portfolio

    Going beyond the traditional fixed income sectors to tap into the potential of securitisation.

    Read more

    Everyday life disrupted: opportunities in a smart home hub

    Smart home technology is unlocking a culture of convenience and driving long-term growth opportunities.

    Read more

    IoT in a new decade: where and what’s next

    The Internet of Things (IoT) is creating a new digital landscape that impacts almost everything from the way how vehicles run to how factories operate. We seek out the opportunities.

    Read more

    Optimising flexible fixed income as inflation bites

    Going across the full spectrum of fixed income to navigate an inflationary environment.

    Read more

    Securitisation 101: What are ABS and MBS?

    Fixed income isn’t just government or corporate bonds, it also includes non-traditional debt securities.

    Read more

    Securitisation: Then and now

    The securitisation market has regained much ground in the past decade.

    Read more

    The secret to effective diversification

    Diversification sounds easy, but how to do it effectively?

    Read more
    lets-solve-it-logo

    For Fund or Institutional enquiries, please call or email us. You can also contact your financial advisor or your J.P.Morgan Representative.

    (65) 6882 1328

    singapore.investor.services@jpmorgan.com

    JPMorgan Asset Management

    • Terms of Use
    • Privacy Statement
    • Cookies Policy
    • Investment stewardship
    • Sitemap
    J.P. Morgan

    • J.P. Morgan
    • JPMorgan Chase
    • Chase

    The information contained herein is intended only for use by Singapore residents. By using this information, you are representing and warranting that you are either residing in Singapore or the applicable laws and regulations of your jurisdiction allow you to access the information, and you confirm that you accept the Terms of Use as set out in https://www.jpmorgan.com/sg/am/per/. Investment involves risk. Past performance is not indicative of future performance. In particular, funds which are invested in emerging markets and smaller companies may involve a higher degree of risk and are usually more sensitive to price movements. Investors should carefully read and consider the fund offering document(s), which contain details on investment objectives, risk factors, charges and expenses of the fund, before making any investment decisions. Information in this website does not constitute investment advice, or an offer to sell, or a solicitation of an offer to buy any security, investment product or service, nor a distribution of information for any such purpose. Informational sources are considered reliable but you should conduct your own verification of information contained herein. Issued by JPMorgan Asset Management (Singapore) Limited. This advertisement or publication has not been reviewed by the Monetary Authority of Singapore (“MAS”).

     

    JPMorgan Asset Management (Singapore) Ltd is regulated by the Monetary Authority of Singapore. (Co. Reg. No. 197601586K)